This Action aims at using innovative translational research to identify colorectal cancer biomarkers for personalized medicine that will improve screening, early detection and disease follow-up, and attain better tumor profiling, state-of-the-art functional characterization of genetic variants and new therapy approaches

Read more

  • Cooperation studies on inherited susceptibility to colorectal cancer
  • TRANSCOLONCAN Group
  • Graphic

News

Special issue entitled "Novel Insight in the Ethology of CRC: Genetics, Diagnosis, Management and Risk Assessment"

Wednesday, 5 May 2021

The COST Association is launching virtual networking tools to complement the current activities and improve virtual collaboration during the current pandemic.Dr Mev Dominguez-Valentin, participant of COST Action TRANSCOLONCAN from the Norwegian Radium Hospital in Oslo, has been appointed, together with Dr Pål Moller, guest editor of the special issue in the Cancers journal entitled "Novel Insight in the Ethology of CRC: Genetics, Diagnosis, Management and Risk Assessment

More about "Special issue entitled "Novel Insight in the Ethology of CRC: Genetics, Diagnosis, Management and Risk Assessment""


COST is supported by the EU Framework Programme Horizon 2020